In addition, our results indicate increased synthesis of TAF1-32i in XDP, given that even upon cycloheximide treatment, levels of this transcript are higher in cells from XDP patients as compared to non-carriers of the SVA insertion. This evidence concerns the gene TAF1 and X-linked dystonia-parkinsonism.